|
1
|
Menné T, Johansen JD, Sommerlund M and
Veien NK: Danish Contact Dermatitis Group: Hand eczema guidelines
based on the Danish guidelines for the diagnosis and treatment of
hand eczema. Contact Dermatitis. 65:3–12. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Diepgen TL, Elsner P, Schliemann S,
Fartasch M, Köllner A, Skudlik C, John SM and Worm M: Deutsche
Dermatologische Gesellschaft: Guideline on the management of hand
eczema ICD-10 Code: L20 L23. L24. L25. L30. J Dtsch Dermatol Ges.
7(Suppl 3): S1–16. 2009.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
3
|
English J, Aldridge R, Gawkrodger DJ,
Kownacki S, Statham B, White JM and Williams J: Consensus statement
on the management of chronic hand eczema. Clin Exp Dermatol.
34:761–769. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Apfelbacher C, Molin S, Weisshaar E, Bauer
A, Elsner P, Mahler V, Weiss M, Ruzicka T and Diepgen TL:
Characteristics and provision of care in patients with chronic hand
eczema: Updated data from the CARPE registry. Acta Derm Venereol.
94:163–167. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Krejci-Manwaring J, McCarty MA, Camacho F,
Manuel J, Hartle J, Fleischer A Jr and Feldman SR: Topical
tacrolimus 0.1% improves symptoms of hand dermatitis in patients
treated with a prednisone taper. J Drugs Dermatol. 7:643–646.
2008.PubMed/NCBI
|
|
6
|
Bauer A, Lange N, Matterne U, Meurer M,
Braeutigam M and Diepgen TL: Efficacy of pimecrolimus 1% cream in
the long term management of atopic hand dermatitis. A double-blind
RCT. J Dtsch Dermatol Ges. 10:426–433. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gritiyarangsan P, Sukhum A, Tresukosol P
and Kullavanijaya P: Topical PUVA therapy for chronic hand eczema.
J Dermatol. 25:299–301. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lynde C, Guenther L, Diepgen TL,
Sasseville D, Poulin Y, Gulliver W, Agner T, Barber K, Bissonnette
R, Ho V, et al: Canadian hand dermatitis management guidelines. J
Cutan Med Surg. 14:267–284. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schindler M, Drozdenko G, Kühl AA and Worm
M: Immunomodulation in patients with chronic hand eczema treated
with oral alitretinoin. Int Arch Allergy Immunol. 165:18–26. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ham K, Maini P and Gooderham MJ:
Real-world experience with alitretinoin in a community dermatology
practice setting in patients with chronic hand dermatitis. J Cutan
Med Surg. 18:332–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gola M, Milanesi N and Derme AM: Clinical
evaluation and assessment of the therapeutic efficacy of
alitretinoin in a group of patients with chronic hand eczema
refractory to topical steroid therapy. G Ital Dermatol Venereol.
149:435–439. 2014.PubMed/NCBI
|
|
12
|
Schmith GD, Singh R, Gomeni R, Graff O,
Hamedani AG, Troughton JS and Learned SM: Use of longitudinal
dose-response modeling to support the efficacy and tolerability of
alitretinoin in severe refractory chronic hand eczema (CHE). CPT
Pharmacometrics Syst Pharmacol. 4:255–262. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mrowietz U, Klein CE, Reich K, Rosenbach
T, Ruzicka T, Sebastian M and Werfel T: Cyclosporine therapy in
dermatology. J Dtsch Dermatol Ges. 7:474–479. 2009.(In German).
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
de León FJ, Berbegal L and Silvestre JF:
Management of chronic hand eczema. Actas Dermosifiliogr. May
21–2015.(Epub ahead of print) (In Spanish).
|
|
15
|
Egawa K: Topical vitamin D3 derivatives in
treating hyperkeratotic palmoplantar eczema: A report of five
patients. J Dermatol. 32:381–386. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Simonsen LI, Høy G, Didriksen E, Persson
J, Melchior N and Hansen J: Development of a new formulation
combining calcipotriol and betamethasone dipropionate in an
ointment vehicle. Drug Dev Ind Pharm. 30:1095–1102. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gola M, D'Erme AM and Milanesi N: Clinical
efficacy of two topical corticosteroids in the management of
chronic hand eczema. G Ital Dermatol Venereol. 150:293–296.
2015.PubMed/NCBI
|
|
18
|
Vakirlis E, Kastanis A and Ioannides D:
Calcipotriol/betamethasone dipropionate in the treatment of
psoriasis vulgaris. Ther Clin Risk Manag. 4:141–148.
2008.PubMed/NCBI
|
|
19
|
McCormack PL: Calcipotriol/betamethasone
dipropionate: A review of its use in the treatment of psoriasis
vulgaris of the trunk, limbs and scalp. Drugs. 71:709–730. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McCormack PL: Spotlight on
calcipotriene/betamethasone dipropionate in psoriasis vulgaris of
the trunk, limbs and scalp. Am J Clin Dermatol. 12:421–424. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kragballe K, Austad J, Barnes L, Bibby A,
de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Williams Z,
Rey J Peyri, et al: Efficacy results of a 52-week, randomised,
double-blind, safety study of a calcipotriol/betamethasone
dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in
the treatment of psoriasis vulgaris. Dermatology. 213:319–326.
2006. View Article : Google Scholar : PubMed/NCBI
|
